News
Untreatable Lung Cancer Patients Get Breakthrough Treatment
The head of the NHS revealed today that a breakthrough targeted medication treating lung cancer would be made accessible to anybody who qualifies, owing...
News
Exclusive license for Croda to commercialise SSI’s CAF vaccine adjuvants
Croda International Plc, which uses smart science to improve lives, announces that it has entered a strategic collaboration with Statens Serum Institut (“SSI”), the...
Press Releases
Vetter’s extraordinary performance sweeps the board at the 2022 CMO Leadership Awards
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), won the 2022 CMO Leadership Awards in all six core categories – quality, expertise,...
Drug Research
Ray Therapeutics and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership
Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions, and Forge Biologics, a gene therapy-focused contract development and...
Clinical Trials
IQVIA selected to accelerate clinical development of VYVGART by argenx SE
IQVIA announced an agreement today with argenx SE. The multi-year contract covers a unique collaboration for the development of new indications for VYVGART™ (efgartigimod...
News
AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio
AbbVie announced it has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's neuroscience portfolio. This acquisition gives AbbVie access...
Press Releases
Element Partners with Interpretation Expert Genoox to Validate the AVITI System for the RUGD Application
Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, announced a partnership with Genoox, a community-driven genomic data platform, to demonstrate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read